IL37 and rheumatoid arthritis: Furthermore, IL-37 has been shown to suppress TNF-α–induced pyroptosis in RA fibroblast-like synoviocytes (RA-FLSs) by blocking the NF-κB/GSDMD pathway, highlighting potential adjunct therapeutic strategies [66].